News

print


Product News and Articles

1 - 10 of 35 Articles 1 2 3 Next Next

11/22/2016

Bio-Rad Announces CE Marking of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

Bio-Rad Laboratories, Inc. today announced CE IVD marking for its BioPlex 2200 Syphilis Total & RPR assay, a novel universal testing method to aid in the diagnosis of syphilis infection.
More »

10/24/2016

Bio-Rad Introduces its IH-1000 Blood Typing System for the U.S. Market

Bio-Rad Laboratories, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IH-1000 blood typing instrument along with approvals for a wide range of associated gel cards and reagents for the U.S. blood typing market.
More »

08/03/2016

Amplichek I Quality Control

Bio-Rad Launches Amplichek I Quality Control, the Second in a Series of Controls for the Molecular Diagnostics Testing Market
More »

06/06/2016

Liquichek™ Maternal Serum II Control

Bio-Rad Announces the Release of Liquichek™ Maternal Serum II Control. The Multi-Constituent Control Offers Increased Efficiency and Confidence in Test Results.
More »

02/26/2016

Bio-Rad Announces CE IVD Marking of its QX200 Droplet Digital PCR System for Use as an In Vitro Diagnostic

Researchers can use the QX200 system for highly-accurate detection and quantification of nucleic acids, aiding clinical decision-making in the treatment of diseases ranging from cancer to transplant rejection and viral infection.
More »

09/28/2015

Bio-Rad Unveils Critical Raw Material Antigens for Diagnostic Uses

Bio-Rad announced the launch of human recombinant protein antigens, which expand the company’s critical raw material offering.
More »

08/25/2015

Bio-Rad Mission: Control™ Risk Management Software Launched at AACC in Atlanta

Bio-Rad Laboratories announced the launch of Bio-Rad Mission: Control™, the first objective risk management software to help laboratories identify the best QC rules and the right QC frequency to develop a customized quality control plan to deliver reliable test results.
More »

08/06/2015

New Lyphochek® Allergen sIgE Controls

Bio-Rad Releases New Lyphochek® Allergen sIgE Controls to Monitor Precision of In Vitro Allergy Test Procedures. Offering Cost Savings, Increased Efficiencies, and Less Waste
More »

06/16/2015

Important Information for Bio-Rad Customers in North America: Business Systems Update

Bio-Rad Laboratories will complete a business systems update on July 6. Impacts to business operations will be minimal, but North American customers should note that Bio-Rad will not ship products from July 1–July 5; shipping will resume on July 6. New customer account numbers and other changes to customer-facing data formats will also be implemented on this date.
More »

11/21/2014

Geenius HIV-1/HIV-2 Supplemental Assay Press Release

Bio-Rad Laboratories' Geenius HIV-1/HIV-2 Supplemental Assay can differentiate circulating antibodies to Human Immunodeficiency Virus Types 1 and 2 in whole blood, serum and plasma. Earlier this month, the company announced that it received Premarket Application Approval from the U.S. Food and Drug Administration for the assay.
More »

Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.